Paul Talmo - Oct 24, 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Technology Officer
Signature
/s/ Megan Smeykal, Attorney-in-fact
Stock symbol
TELA
Transactions as of
Oct 24, 2024
Transactions value $
$50,000
Form type
4
Date filed
10/24/2024, 04:25 PM
Previous filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Purchase $50K +22.2K +32.27% $2.25 91.1K Oct 24, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in the Issuer's underwritten public offering that closed on October 24, 2024, at the public offering price of $2.25 per share.